NCT02370108UnknownPhase 1
The Study of Rest Tremor Suppression by Using Electrical Muscle Stimulation
Conditions
Interventions
Trial Snapshot
- Phase
- Phase 1
- Sponsor
- Chulalongkorn University
- Enrollment
- 60
- Primary Endpoint
- Number of participant who had tremor suppression determine by reduction of tremor rating scale during electrical muscle stimulation
Study Overview
Brief Summary
This study is aimed to study the safety and feasibility of electrical muscle stimulation (EMS) in suppression of tremor from various causes especially for rest tremor in Parkinson's disease.
Detailed Description
Study method as follows:
- All subjects will be provided the information on this research study and informed consent will be sought for every subjects.
- All subjects (30 PD patients and 30 others tremor patients) will be interviewed by a movement disorders specialist or a trained interviewer for their demographic and clinical data.
- All PD patients will be examined for the severity of Parkinson's disease by a movement disorders specialist according the Unified Parkinson's disease Rating Scale (UPDRS), Hoehn and Yahr score, and tremor rating scale, during the 'on period' in order to determine the additional effect of EMS for suppression of tremor. Physical examinations of each patient will be recorded by the video recording for later reviewed.
- All essential tremor and dystonic tremor patients will be examined by a movement disorders specialist for the tremor severity according to the Fahn, Tolosa, Marin Tremor Rating Scale. Physical examinations of each patient will be recorded by the video recording for later reviewed.
All patient will be determined for feasibility to use EMS and safety of EMS. Pain will determined by visual analog scale.
- All patients will be monitored their hand tremor at resting position and postural position. The tremor analysis with accelerometer and gyroscope system (Parkinson Monitor V0.006 Beta) and the surface EMG (Nicolet EDX Viking) will be conducted. The surface EMG electrode will place over thenar muscle of the hand, which is the most predominant sided of tremor, for quantitative measurement and determination of tremor physiology.
- All participants data from surface EMG will be applied to The Matlab™ program (MathWorks Inc.) in order to modify the qualitative signals into quantitative parameters and performing the high-dimensional feature vectors, and later to determine the different efficacy in pulse amplitude of electrical muscle stimulation on feature vectors.
- The electrical muscle stimulation (Intensity™ Twin Stim® III) will be conducted by placement the 2 self-adhesive electrode (size 1.5 inches * 1.5 inches) over thenar muscle and 1st&2nd interrosseous muscle of the hand, which is the most predominant sided of tremor. The EMS will be stimulated PD patients on the rest position, whereas the other tremors patients in both rest position and postural position. The pulse amplitude will be slowly titration until provided the tetanic muscle contraction (motor threshold) without pain (all applied frequency is 50 Hz).
- All of examination will be taken for 30 minutes for each one subject.
Data Collection
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •For PD patients
- •Adults ≥ 18 years old.
- •Patients with Parkinson's disease diagnosed according to the UKPDSBB criteria with predominantly feature of rest tremor that intractable to medically treatment.
- •Informed consent For other tremor patients
- •Adults ≥ 18 years old.
- •Patients with essential tremor diagnosed according to the TRIG criteria for essential tremor or patients with dystonic tremor diagnosed according to the proposed definition in which their symptoms shared similar trait of medically intractable tremor.
- •Informed consent
Exclusion Criteria
- •For PD patients
- •Patients with a history of cardiac arrhythmia, renal failure, hepatic failure, and pregnancy as well as those who had history of seizure or had the risk for tended to become seizure such as those who had focal brain lesions, encephalitis, and stroke patients.
- •Patients with a history of hand surgery and implanted screws or wires in hand area that supposed to place a surface EMG or EMS, as well as those patients who were implanted for electrical devices such as cardiac pacemaker, pulse generator of deep brain stimulation,and intrathecal baclofen pump.
- •Patients who cannot avoid the medication that may potentiate or attenuate tremor such as antihistamines, benzodiazepine, illicit drugs, and thyroid hormone supplement.
- •For other tremor patients
- •Patients with a history of cardiac arrhythmia, renal failure, hepatic failure, and pregnancy as well as those who had history of seizure or had the risk for tended to become seizure such as those who had focal brain lesions, encephalitis, and stroke patients.
- •Patients with a history of hand surgery and implanted screws or wires in hand area that supposed to place a surface EMG or EMS, as well as those patients who were implanted for electrical devices such as cardiac pacemaker, pulse generator of deep brain stimulation, and intrathecal baclofen pump.
- •Patients who cannot avoid the medication that may potentiate or attenuate tremor such as antihistamines, benzodiazepine, illicit drugs, and thyroid hormone supplement.
Arms & Interventions
PD patient
Experimental
Parkinson's disease patients will get the electrical muscle stimulation at the most tremulous hand at 50 Hz frequency, maximal tolerate pulse amplitude (not over 20 mA), duration of stimulation for 10 second.
Intervention: electrical muscle stimulation (Device)
OT patients
Experimental
others tremor patients will get the electrical muscle stimulation at the most tremulous hand at 50 Hz frequency, maximal tolerate pulse amplitude (not over 20 mA), duration of stimulation for 10 second.
Intervention: electrical muscle stimulation (Device)
Outcomes
Primary Outcomes
Number of participant who had tremor suppression determine by reduction of tremor rating scale during electrical muscle stimulation
Time Frame: up to 1 month follow up
To determine the number of participant with tremor suppression during electrical muscle stimulation
Secondary Outcomes
- Number of participant who report pain or any adverse events from electrical muscle stimulation(up to 1 month follow up)
- The severity of pain related from electrical muscle stimulation by visual analog scale(intraoperative)
Investigators
Similar Trials
Unknown
Phase 2
Electrical Muscle Stimulation (EMS), a Preventive and Therapeutic Tool for Critical Illness Polyneuromyopathy (CIPNM)Critical Illness Polyneuromyopathy (CIPNM)ICU Acquired Weakness (ICUAW)NCT00882830University of Athens52
Completed
Not Applicable
The Use of NMES With Pelvic Fracture RehabilitationFractures, ClosedNCT03298425Barts & The London NHS Trust58
Recruiting
Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain SyndromePatellofemoral Pain SyndromeNCT03184545Northwell Health92
Withdrawn
Not Applicable
The Essential Tremor (ET) and Parkinson Disease (PD) Tremor Acute Stimulation StudyParkinson DiseaseEssential TremorNCT01940406BlueWind Medical
Completed
Phase 1
The study of the effect of electrical muscle stimulation on the prevention of deep vein thrombosis in emergency patients with prolonged immobility:randomised cotorolled trial.emergency patients with prolonged immobilityJPRN-UMIN000013642Department of Traumatology and Acute Critical Medicine Osaka University Graduate School of Medicine150